7LXY

SARS-CoV-2 S/S2M11/S2X333 Global Refinement

7LXY の概要

• エントリーDOI: 10.2210/pdb7lxy/pdb
• EMDBエントリー: 23579
• 分子名称: Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, ... (9 entities in total)
• 機能のキーワード: antibody, viral protein, structural genomics, seattle structural genomics center for infectious disease, ssgcid, viral protein-immune system complex, viral protein/immune system
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2); 詳細
• タンパク質・核酸の鎖数: 15
• 化学式量合計: 588987.97

構造登録者

McCallum, M.,Veesler, D.,Seattle Structural Genomics Center for Infectious Disease (SSGCID) (登録日: 2021-03-05, 公開日: 2021-04-14, 最終更新日: 2021-05-12)

• 主引用文献: McCallum, M.,De Marco, A.,Lempp, F.A.,Tortorici, M.A.,Pinto, D.,Walls, A.C.,Beltramello, M.,Chen, A.,Liu, Z.,Zatta, F.,Zepeda, S.,di Iulio, J.,Bowen, J.E.,Montiel-Ruiz, M.,Zhou, J.,Rosen, L.E.,Bianchi, S.,Guarino, B.,Fregni, C.S.,Abdelnabi, R.,Foo, S.C.,Rothlauf, P.W.,Bloyet, L.M.,Benigni, F.,Cameroni, E.,Neyts, J.,Riva, A.,Snell, G.,Telenti, A.,Whelan, S.P.J.,Virgin, H.W.,Corti, D.,Pizzuto, M.S.,Veesler, D.; N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.; Cell, 184:2332-, 2021; PubMed: 33761326; DOI: 10.1016/j.cell.2021.03.028

実験手法